Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 3 | 2019 | 191 | 1.100 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2022 | 1143 | 0.980 |
Why?
|
| Cerebral Hemorrhage | 5 | 2022 | 109 | 0.830 |
Why?
|
| Brain Mapping | 6 | 2021 | 150 | 0.810 |
Why?
|
| Blood Glucose | 2 | 2020 | 108 | 0.800 |
Why?
|
| Biomarkers | 3 | 2020 | 596 | 0.690 |
Why?
|
| Neuregulins | 1 | 2019 | 1 | 0.670 |
Why?
|
| Headache | 1 | 2019 | 34 | 0.650 |
Why?
|
| Mean Platelet Volume | 1 | 2018 | 1 | 0.630 |
Why?
|
| Diabetic Nephropathies | 1 | 2018 | 22 | 0.620 |
Why?
|
| Lymphocytes | 1 | 2018 | 63 | 0.610 |
Why?
|
| Circle of Willis | 1 | 2017 | 5 | 0.560 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2017 | 24 | 0.550 |
Why?
|
| Sclerosis | 1 | 2017 | 66 | 0.550 |
Why?
|
| Temporal Lobe | 1 | 2017 | 84 | 0.540 |
Why?
|
| Thalamus | 4 | 2021 | 16 | 0.510 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 5 | 2022 | 94 | 0.500 |
Why?
|
| Image Enhancement | 2 | 2020 | 49 | 0.490 |
Why?
|
| Middle Aged | 22 | 2021 | 9269 | 0.480 |
Why?
|
| Adult | 22 | 2021 | 8107 | 0.470 |
Why?
|
| Humans | 43 | 2022 | 28436 | 0.460 |
Why?
|
| Female | 27 | 2021 | 15730 | 0.460 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2021 | 63 | 0.450 |
Why?
|
| Male | 27 | 2021 | 15291 | 0.430 |
Why?
|
| Brain | 6 | 2021 | 1663 | 0.420 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2010 | 67 | 0.390 |
Why?
|
| Diagnostic Imaging | 2 | 2020 | 80 | 0.370 |
Why?
|
| Brain Ischemia | 2 | 2021 | 63 | 0.340 |
Why?
|
| Aged | 14 | 2021 | 9277 | 0.330 |
Why?
|
| Evoked Potentials, Motor | 1 | 2009 | 9 | 0.320 |
Why?
|
| Motor Cortex | 1 | 2009 | 17 | 0.320 |
Why?
|
| Brain Diseases | 1 | 2009 | 67 | 0.310 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 124 | 0.300 |
Why?
|
| Young Adult | 6 | 2021 | 2069 | 0.300 |
Why?
|
| Graft Rejection | 2 | 2018 | 71 | 0.280 |
Why?
|
| Contrast Media | 3 | 2020 | 75 | 0.280 |
Why?
|
| Liver Transplantation | 2 | 2018 | 96 | 0.270 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 933 | 0.260 |
Why?
|
| Auditory Cortex | 1 | 2005 | 2 | 0.250 |
Why?
|
| Case-Control Studies | 4 | 2021 | 594 | 0.250 |
Why?
|
| Language | 1 | 2005 | 71 | 0.240 |
Why?
|
| Risk Factors | 7 | 2021 | 2408 | 0.240 |
Why?
|
| Sex Characteristics | 1 | 2005 | 118 | 0.230 |
Why?
|
| Postoperative Complications | 3 | 2020 | 932 | 0.220 |
Why?
|
| Brain Neoplasms | 2 | 2021 | 88 | 0.220 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2008 | 31 | 0.210 |
Why?
|
| Turkey | 2 | 2018 | 6 | 0.190 |
Why?
|
| Radiology | 1 | 2021 | 16 | 0.190 |
Why?
|
| Encephalocele | 1 | 2021 | 24 | 0.190 |
Why?
|
| Patient Care Planning | 1 | 2001 | 52 | 0.180 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2001 | 48 | 0.180 |
Why?
|
| Retrospective Studies | 9 | 2021 | 3612 | 0.180 |
Why?
|
| Glioma | 1 | 2021 | 20 | 0.180 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 94 | 0.180 |
Why?
|
| Adenolymphoma | 1 | 2020 | 4 | 0.180 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2020 | 6 | 0.180 |
Why?
|
| Antiviral Agents | 1 | 2021 | 71 | 0.180 |
Why?
|
| Nerve Net | 1 | 2021 | 41 | 0.180 |
Why?
|
| Thyroid Neoplasms | 2 | 2017 | 44 | 0.180 |
Why?
|
| Facial Nerve | 1 | 2020 | 13 | 0.180 |
Why?
|
| Kidney Neoplasms | 1 | 2001 | 79 | 0.180 |
Why?
|
| Parotid Gland | 1 | 2020 | 18 | 0.180 |
Why?
|
| Dissection | 1 | 2020 | 25 | 0.180 |
Why?
|
| Parotid Neoplasms | 1 | 2020 | 14 | 0.180 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2020 | 24 | 0.180 |
Why?
|
| Hyperglycemia | 1 | 2020 | 32 | 0.180 |
Why?
|
| Gray Matter | 1 | 2021 | 51 | 0.180 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2020 | 7 | 0.170 |
Why?
|
| Hospital Mortality | 1 | 2021 | 147 | 0.170 |
Why?
|
| Artifacts | 1 | 2020 | 33 | 0.170 |
Why?
|
| Kidney | 1 | 2001 | 175 | 0.170 |
Why?
|
| White Matter | 2 | 2019 | 134 | 0.170 |
Why?
|
| Fasting | 1 | 2019 | 22 | 0.170 |
Why?
|
| Hernia | 1 | 2019 | 9 | 0.170 |
Why?
|
| Brain Edema | 1 | 2019 | 18 | 0.170 |
Why?
|
| Liver Neoplasms | 2 | 2018 | 105 | 0.160 |
Why?
|
| Neuroma, Acoustic | 1 | 2019 | 10 | 0.160 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 161 | 0.160 |
Why?
|
| Movement | 1 | 2020 | 117 | 0.160 |
Why?
|
| Emergencies | 1 | 2019 | 36 | 0.160 |
Why?
|
| Acute Disease | 2 | 2019 | 208 | 0.160 |
Why?
|
| Sarcoidosis | 1 | 2019 | 14 | 0.160 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 18 | 0.160 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 7 | 0.160 |
Why?
|
| Diabetes, Gestational | 1 | 2019 | 9 | 0.160 |
Why?
|
| Recovery of Function | 1 | 2020 | 300 | 0.160 |
Why?
|
| Spinal Cord Diseases | 1 | 2019 | 48 | 0.160 |
Why?
|
| Stomach | 1 | 2018 | 15 | 0.160 |
Why?
|
| Lymphocyte Count | 1 | 2018 | 16 | 0.160 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 28 | 0.160 |
Why?
|
| Cerebral Angiography | 1 | 2018 | 35 | 0.160 |
Why?
|
| Obesity, Abdominal | 1 | 2018 | 19 | 0.160 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 135 | 0.160 |
Why?
|
| Adiposity | 1 | 2019 | 42 | 0.150 |
Why?
|
| Brain Abscess | 1 | 2018 | 5 | 0.150 |
Why?
|
| Weight Gain | 1 | 2019 | 66 | 0.150 |
Why?
|
| Cystic Fibrosis | 1 | 2018 | 10 | 0.150 |
Why?
|
| Intra-Abdominal Fat | 1 | 2018 | 41 | 0.150 |
Why?
|
| Intracranial Pressure | 1 | 2018 | 13 | 0.150 |
Why?
|
| Pediatric Obesity | 1 | 2019 | 49 | 0.150 |
Why?
|
| Nerve Fibers | 1 | 2018 | 12 | 0.150 |
Why?
|
| Child Development | 1 | 2019 | 75 | 0.150 |
Why?
|
| Spinal Diseases | 1 | 2019 | 113 | 0.150 |
Why?
|
| Adolescent | 4 | 2020 | 2307 | 0.150 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2018 | 27 | 0.150 |
Why?
|
| Cerebrovascular Disorders | 1 | 2019 | 134 | 0.150 |
Why?
|
| Erythrocyte Indices | 1 | 2017 | 5 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 206 | 0.140 |
Why?
|
| Pregnancy | 1 | 2019 | 342 | 0.140 |
Why?
|
| Thyroid Nodule | 1 | 2017 | 9 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2018 | 169 | 0.140 |
Why?
|
| Biliary Tract | 1 | 2017 | 3 | 0.140 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 2017 | 3 | 0.140 |
Why?
|
| Kidney Diseases | 1 | 2018 | 109 | 0.140 |
Why?
|
| Cysts | 1 | 2017 | 18 | 0.140 |
Why?
|
| Anastomosis, Surgical | 1 | 2017 | 30 | 0.140 |
Why?
|
| Leukoencephalopathies | 1 | 2017 | 12 | 0.140 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 33 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2018 | 730 | 0.140 |
Why?
|
| Calcinosis | 1 | 2017 | 49 | 0.140 |
Why?
|
| Epithalamus | 1 | 2016 | 2 | 0.140 |
Why?
|
| Afferent Pathways | 1 | 2016 | 4 | 0.140 |
Why?
|
| Functional Laterality | 1 | 2017 | 62 | 0.140 |
Why?
|
| Sensitivity and Specificity | 4 | 2022 | 517 | 0.130 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 259 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 190 | 0.130 |
Why?
|
| Cervical Vertebrae | 1 | 2019 | 288 | 0.130 |
Why?
|
| Prospective Studies | 5 | 2021 | 1809 | 0.130 |
Why?
|
| Radiopharmaceuticals | 2 | 2010 | 53 | 0.120 |
Why?
|
| Stroke | 1 | 2018 | 276 | 0.120 |
Why?
|
| Child | 3 | 2021 | 1420 | 0.120 |
Why?
|
| Dominance, Cerebral | 2 | 2005 | 16 | 0.120 |
Why?
|
| Corpus Callosum | 2 | 2019 | 12 | 0.110 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 4857 | 0.110 |
Why?
|
| Spinal Fusion | 1 | 2020 | 465 | 0.110 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2006 | 199 | 0.110 |
Why?
|
| Parkinson Disease | 2 | 2018 | 859 | 0.100 |
Why?
|
| Prognosis | 3 | 2020 | 825 | 0.100 |
Why?
|
| Time Factors | 3 | 2020 | 1491 | 0.090 |
Why?
|
| Aging | 1 | 2019 | 1550 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 1859 | 0.080 |
Why?
|
| Dementia, Vascular | 1 | 2010 | 45 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 492 | 0.080 |
Why?
|
| Neuroradiography | 1 | 2009 | 2 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 372 | 0.080 |
Why?
|
| Subclavian Artery | 1 | 2008 | 3 | 0.080 |
Why?
|
| Vertebral Artery | 1 | 2008 | 4 | 0.080 |
Why?
|
| Pediatrics | 1 | 2009 | 46 | 0.080 |
Why?
|
| Reference Values | 1 | 2009 | 194 | 0.080 |
Why?
|
| Echo-Planar Imaging | 2 | 2005 | 4 | 0.080 |
Why?
|
| Hospitalization | 2 | 2021 | 323 | 0.080 |
Why?
|
| Thallium Radioisotopes | 3 | 1999 | 5 | 0.070 |
Why?
|
| Technetium Tc 99m Sestamibi | 3 | 1999 | 11 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2009 | 440 | 0.070 |
Why?
|
| Graft Survival | 2 | 2018 | 102 | 0.070 |
Why?
|
| Organotechnetium Compounds | 3 | 1999 | 8 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2021 | 677 | 0.070 |
Why?
|
| Survival Rate | 2 | 2018 | 356 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 737 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2006 | 65 | 0.070 |
Why?
|
| Body Mass Index | 2 | 2019 | 465 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1384 | 0.060 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2003 | 13 | 0.050 |
Why?
|
| Frontal Sinus | 1 | 2003 | 13 | 0.050 |
Why?
|
| Aphasia, Broca | 1 | 2003 | 2 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2003 | 8 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2003 | 14 | 0.050 |
Why?
|
| Astrocytoma | 1 | 2003 | 20 | 0.050 |
Why?
|
| Frontal Lobe | 1 | 2003 | 81 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2003 | 47 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2019 | 688 | 0.050 |
Why?
|
| Blindness | 1 | 2022 | 12 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2021 | 3615 | 0.050 |
Why?
|
| Iliac Artery | 1 | 2001 | 5 | 0.050 |
Why?
|
| Renal Artery | 1 | 2001 | 8 | 0.050 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 1 | 2021 | 3 | 0.050 |
Why?
|
| Petrous Bone | 1 | 2021 | 5 | 0.050 |
Why?
|
| Pelvis | 1 | 2001 | 31 | 0.050 |
Why?
|
| Prevalence | 2 | 2018 | 468 | 0.050 |
Why?
|
| Multimodal Imaging | 1 | 2021 | 28 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2020 | 39 | 0.040 |
Why?
|
| Globus Pallidus | 1 | 2019 | 11 | 0.040 |
Why?
|
| Caudate Nucleus | 1 | 2019 | 11 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 41 | 0.040 |
Why?
|
| Spine | 1 | 2020 | 108 | 0.040 |
Why?
|
| Radionuclide Imaging | 5 | 1999 | 43 | 0.040 |
Why?
|
| Sex Factors | 1 | 2021 | 476 | 0.040 |
Why?
|
| Carcinoma, Medullary | 1 | 1999 | 6 | 0.040 |
Why?
|
| Tennessee | 1 | 2018 | 9 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 127 | 0.040 |
Why?
|
| Ileum | 1 | 2018 | 17 | 0.040 |
Why?
|
| Gastrointestinal Transit | 1 | 1998 | 11 | 0.040 |
Why?
|
| Intestinal Diseases | 1 | 2018 | 9 | 0.040 |
Why?
|
| Bacterial Translocation | 1 | 1998 | 23 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 2018 | 23 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2018 | 62 | 0.040 |
Why?
|
| ROC Curve | 1 | 2018 | 144 | 0.040 |
Why?
|
| Pseudomonas Infections | 1 | 2018 | 50 | 0.040 |
Why?
|
| Intestines | 1 | 1998 | 99 | 0.040 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 62 | 0.040 |
Why?
|
| Thyroidectomy | 1 | 2017 | 19 | 0.040 |
Why?
|
| Smoking | 1 | 2018 | 177 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 137 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2018 | 125 | 0.040 |
Why?
|
| Habenula | 1 | 2016 | 2 | 0.030 |
Why?
|
| Infant | 1 | 2019 | 587 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 329 | 0.030 |
Why?
|
| Mothers | 1 | 2019 | 193 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2019 | 654 | 0.030 |
Why?
|
| Deep Brain Stimulation | 1 | 2016 | 40 | 0.030 |
Why?
|
| Succimer | 1 | 1995 | 1 | 0.030 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1995 | 2 | 0.030 |
Why?
|
| Hemangioma | 1 | 1995 | 8 | 0.030 |
Why?
|
| Thymoma | 1 | 1995 | 7 | 0.030 |
Why?
|
| Thymus Neoplasms | 1 | 1995 | 11 | 0.030 |
Why?
|
| Thymus Gland | 1 | 1995 | 11 | 0.030 |
Why?
|
| Parathyroid Glands | 1 | 1995 | 8 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 383 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 372 | 0.030 |
Why?
|
| Sugar Acids | 1 | 1994 | 2 | 0.030 |
Why?
|
| Behcet Syndrome | 1 | 1994 | 4 | 0.030 |
Why?
|
| Uveitis | 1 | 1994 | 10 | 0.030 |
Why?
|
| United States | 1 | 2019 | 2201 | 0.020 |
Why?
|
| Arteritis | 1 | 2008 | 1 | 0.020 |
Why?
|
| Aneurysm | 1 | 2008 | 10 | 0.020 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 2 | 1999 | 2 | 0.020 |
Why?
|
| Medical Illustration | 1 | 2006 | 14 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 51 | 0.010 |
Why?
|
| Research Design | 1 | 2003 | 207 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 342 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 1999 | 5 | 0.010 |
Why?
|
| Calcitonin | 1 | 1999 | 17 | 0.010 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1998 | 2 | 0.010 |
Why?
|
| Parasympathomimetics | 1 | 1998 | 4 | 0.010 |
Why?
|
| Neostigmine | 1 | 1998 | 4 | 0.010 |
Why?
|
| Peristalsis | 1 | 1998 | 12 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 52 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1999 | 90 | 0.010 |
Why?
|
| Morphine | 1 | 1998 | 61 | 0.010 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1999 | 54 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1999 | 120 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 1999 | 202 | 0.010 |
Why?
|
| Rats | 1 | 1998 | 678 | 0.010 |
Why?
|
| Parathyroid Neoplasms | 1 | 1995 | 5 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1995 | 36 | 0.010 |
Why?
|
| Adenoma | 1 | 1995 | 60 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1995 | 243 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1999 | 553 | 0.010 |
Why?
|
| Animals | 1 | 1998 | 3780 | 0.010 |
Why?
|